Exponent, Inc. (NASDAQ:EXPO - Free Report) - Analysts at William Blair lowered their Q2 2025 earnings per share estimates for shares of Exponent in a note issued to investors on Friday, May 2nd. William Blair analyst A. Nicholas now forecasts that the business services provider will post earnings of $0.48 per share for the quarter, down from their prior forecast of $0.55. The consensus estimate for Exponent's current full-year earnings is $1.98 per share. William Blair also issued estimates for Exponent's FY2025 earnings at $1.93 EPS, Q2 2026 earnings at $0.58 EPS, Q3 2026 earnings at $0.57 EPS, Q4 2026 earnings at $0.47 EPS and FY2026 earnings at $2.15 EPS.
Exponent Price Performance
Shares of NASDAQ:EXPO traded down $0.33 on Monday, hitting $74.86. The company's stock had a trading volume of 232,661 shares, compared to its average volume of 242,468. The company has a 50-day simple moving average of $80.18 and a 200 day simple moving average of $89.14. The company has a market capitalization of $3.80 billion, a PE ratio of 35.31 and a beta of 0.95. Exponent has a 1 year low of $73.37 and a 1 year high of $115.75.
Exponent (NASDAQ:EXPO - Get Free Report) last issued its quarterly earnings data on Thursday, May 1st. The business services provider reported $0.52 EPS for the quarter, beating the consensus estimate of $0.48 by $0.04. Exponent had a net margin of 19.52% and a return on equity of 27.27%. The company had revenue of $137.44 million during the quarter, compared to analysts' expectations of $134.63 million. During the same quarter in the previous year, the company earned $0.59 earnings per share. Exponent's revenue for the quarter was up .2% on a year-over-year basis.
Exponent Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, June 20th. Shareholders of record on Friday, June 6th will be paid a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 1.60%. The ex-dividend date is Friday, June 6th. Exponent's dividend payout ratio (DPR) is currently 58.54%.
Insiders Place Their Bets
In related news, VP Richard Reiss sold 1,736 shares of the business's stock in a transaction that occurred on Wednesday, February 26th. The stock was sold at an average price of $85.93, for a total value of $149,174.48. Following the completion of the sale, the vice president now owns 1,800 shares in the company, valued at $154,674. The trade was a 49.10 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 2.10% of the company's stock.
Institutional Inflows and Outflows
Several large investors have recently made changes to their positions in EXPO. Private Trust Co. NA grew its holdings in shares of Exponent by 129.8% during the 4th quarter. Private Trust Co. NA now owns 278 shares of the business services provider's stock valued at $25,000 after purchasing an additional 157 shares during the last quarter. Atala Financial Inc bought a new position in shares of Exponent during the fourth quarter valued at about $25,000. Whipplewood Advisors LLC increased its stake in Exponent by 5,333.3% in the 1st quarter. Whipplewood Advisors LLC now owns 326 shares of the business services provider's stock worth $26,000 after purchasing an additional 320 shares during the period. Tortoise Investment Management LLC increased its stake in Exponent by 76.7% in the 4th quarter. Tortoise Investment Management LLC now owns 440 shares of the business services provider's stock worth $39,000 after purchasing an additional 191 shares during the period. Finally, Trust Co. of Vermont bought a new stake in Exponent in the fourth quarter valued at approximately $45,000. 92.37% of the stock is owned by hedge funds and other institutional investors.
Exponent Company Profile
(
Get Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Featured Stories

Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.